Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 31 | 187 | 422 | 786 |
| Cost of Goods | N/A | N/A | N/A | 420 | 810 |
| Gross Profit | N/A | 31 | 187 | 3 | -24 |
| Operating Expenses | 9,135 | 7,707 | 8,041 | 6,525 | 5,445 |
| Operating Income | -9,135 | -7,675 | -7,855 | -6,103 | -4,659 |
| Interest Expense | -4 | -50 | 298 | 210 | 58 |
| Other Income | -4 | 0 | -4,890 | -1,479 | -871 |
| Pre-tax Income | -9,136 | -7,625 | -13,043 | -7,792 | -5,588 |
| Net Income Continuous | -9,136 | -7,625 | -13,043 | -7,792 | -5,588 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 2,201 |
| Net Income | $-9,136 | $-7,625 | $-13,043 | $-7,792 | $-3,388 |
| EPS Basic Total Ops | -264.56 | -424.56 | -1,535.09 | -1,184.21 | -543.86 |
| EPS Basic Continuous Ops | -248.29 | -424.69 | -1,222.07 | -1,115.49 | -859.65 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 315.79 |
| EPS Diluted Total Ops | -264.56 | -424.56 | -1,535.09 | -1,184.21 | -543.86 |
| EPS Diluted Continuous Ops | -248.29 | -424.69 | -1,222.07 | -1,115.49 | -859.65 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 315.79 |
| EPS Diluted Before Non-Recurring Items | -264.56 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-8,751 | $-7,279 | $-1,159 | $-4,254 | $-4,508 |